The groundbreaking development aims to revolutionise healthcare, offering promising solutions to enhance patient care and convenience
Redcliffe Labs has collaborated with Abbott India, a global healthcare giant to introduce Clinical Decision Support (CDS) also known as AlinIQ, powered by various proprietary technologies including Big Data Engines and Artificial Intelligence (AI). This groundbreaking development aims to revolutionise healthcare, offering promising solutions to enhance patient care and convenience.
Redcliffe Labs has taken a significant step forward by becoming the first in the diagnostics industry to adopt the newly launched AI-based AlinIQ Clinical Decision Support system. The rollout took 24 months towards implementing the advanced platform. This cutting-edge technology empowers consumers but also clinicians and other healthcare professionals with unparalleled insights and recommendations, revolutionizing medical decisions.
“At Redcliffe Labs, our unwavering commitment to advancing patient care through innovation and technology has led to the development of the AI-based CDS system,” stated Dheeraj Jain, Founder and MD, Redcliffe Labs. “Our state-of-the-art CDS represents a giant leap forward in the diagnostic healthcare sector, empowering our skilled clinicians with invaluable insights to provide the best possible care for our patients.”
Jamshyed Patrawala, Country Head, Abbott India, emphasised that this integration marks a significant milestone in the diagnostic industry, promising to enhance the overall diagnostics landscape of the country. He believes this advancement will greatly support clinicians and provide better convenience for individuals, as they will receive comprehensive and personalised reports, unveiling their comparative health condition.
The collaboration between Redcliffe Labs and Abbott has been instrumental in successfully implementing the AlinIQ CDS system.
Dr Sohini Sengupta, Medical Laboratory Director, Redcliffe Labs, led the CDS project by enabling the customization of clinical guidelines, which will form the basis for generating personalised patient-centric reports at Redcliffe Labs. These were configured for over a year in close association with Dr Shane Brown, Clinical Consultant at Abbott.
In an era of digital transformation and personalised medicine, Redcliffe Labs’ pioneering initiative with the AI-based CDS System signifies a giant step towards achieving value-based healthcare and enhancing the clinical care continuum for every patient.
